Back

Mitochondrial targeting by Elamipretide improves cardiac mitochondrial function without improving cardiovascular performance in HFpEF

23 April 2026 (12:55 - 13:07)
Organised by: Logo
Congress Presentation Part of: Efficacy of prevention measures and risk factor trajectories Heart Failure EAPC Premium Access ESC Preventive Cardiology 2026 European Association of Preventive Cardiology (EAPC)

About the speaker

Photo
Doctor Antje Schauer

Heart Centre Dresden - Dresden Technical University Hospital, Dresden (Germany)

5 More presentations in this session

Presentation thumbnail
Voting guidelines
Presentation thumbnail
Quiz presentation
Doctor S. Gati (London, GB) Professor V. Vassiliou (Norwich, GB)
Slides Video
Presentation thumbnail
Prescribing cardiorespiratory exercise intensity in cardiac rehabilitation: do updated guidelines capture true individual effort responses?
Doctor J. Milani (Hasselt, BE)
Abstract Slides Video
Presentation thumbnail
Effects of different weekly frequencies of combined training on blood pressure variability in older adults with hypertension
Professor R. Ferrari (Porto Alegre, BR)
Abstract Slides
Presentation thumbnail
Digital lifestyle re-engineering with maintenance phase design: The TOP-S randomised clinical trial in metabolic syndrome management
Ms B. Chan (Hong Kong, HK)
Abstract Slides Video

Access the full session

Session thumbnail
Efficacy of prevention measures and risk factor trajectories
Video

The Event

Event poster

ESC Preventive Cardiology 2026

23 April 2026 12:55 CET
You may be interested in
thumbnail
Congress Session
Young Investigator Award (YIA) Basic Science
thumbnail
Congress Session
Basic and Translational Late-Breaking Science session
thumbnail
Congress Session
Identifying and treating metabolic issues in heart failure

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources